Stock Day Media

Skylight Health Completes Acquisition of Primary Care Clinic Group, Rocky Mountain with 7 Locations in Colorado (SHGFF)

April 5, 2021April 5, 2021 Stock Day Media 103 Views clinic, healthcare, SHGFF, skylighthealth

TORONTO, April 05, 2021 (GLOBE NEWSWIRE) — Skylight Health Group Inc (TSXV:SHG; OTCQX: SHGFF) (“Skylight Health” or the “Company”), a

Health

HealthLynked Reports Annual Revenue Growth of 53% and Net Equity Improvement of $4.2M to $1.35M (HLYK)

April 1, 2021April 1, 2021 Stock Day Media 135 Views healthcare, healthlynked, hlyk, latest, revenues

PR Newswire NAPLES, Fla., April 1, 2021 NAPLES, Fla., April 1, 2021 /PRNewswire/ — HealthLynked Corp. (OTCQB: HLYK), a global healthcare network focused

BioTech Health News

Reflect Scientific Ends 2020 Fourth Quarter with Increased Year Over Year Sales (RSCF)

February 23, 2021February 23, 2021 Stock Day Media 345 Views biotechnology, healthcare, industrial, reflect scientific, RSCF

OREM, Utah, Feb. 23, 2021 (GLOBE NEWSWIRE) — Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services

BioTech Health

ISW Holdings Announces Acquisition Plans in Telehealth and Home Healthcare Segment, Targets 500% Topline Growth in 2021

December 30, 2020December 30, 2020 Stock Day Media 385 Views healthcare, ISWH, ISWholdings, telehealth, toplinegrowth

LAS VEGAS, NV, Dec. 30, 2020 (GLOBE NEWSWIRE) — via NewMediaWire –ISW Holdings, Inc. (OTC: ISWH) (“ISW Holdings” or the “Company”), a

Business

Dalrada Financial Corporation Announces Acquisitions In Healthcare And Engineering

December 28, 2020December 28, 2020 Stock Day Media 397 Views axquisitions, dalrada, Engineering, financialcorporation, healthcare

SAN DIEGO, Dec. 28, 2020 /PRNewswire/ — Dalrada Financial Corp. (OTCQB: DFCO, “Dalrada”) is pleased to announce the Company’s latest acquisition and

Uncategorized

RENNOVA HEALTH WELCOMES NEW CHIEF FINANCIAL OFFICER

April 9, 2019April 15, 2019 Marcus Heatherly 484 Views clincal laboratories, ClinLab, credentialing, emergency rooms, financial services, healthcare, medical, Medical Stocks, Medicare, MedyTox, operating rooms, RennovaHealth Inc., RNVA

WEST PALM BEACH, Fla, April 09, 2019 (GLOBE NEWSWIRE) — Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW), (“Rennova” or the “Company”),

BioTech

GT Biopharma Receives Institutional Review Board Approval to Proceed With in Human FDA Phase 1 Clinical Trial

April 8, 2019July 3, 2019 Marcus Heatherly 662 Views acute myelogenous leukemia, advanced and tested, biotechnology company, healthcare, medical, Multi-Target Bispecific Drug Conjugate, Myelodysplastic syndromes, pharmaceutical stocks, Phase 1 Trial, testing

TAMPA, Florida, April 8, 2019 /CNW/ –GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) an immuno-oncology biotechnology company focused on innovative treatments based on

Uncategorized

Todos and Amarantus Announce Completion of LymPro PET 1 Study by Leipzig University for Alzheimer’s Blood Diagnostic LymPro Test 2.0

April 8, 2019April 8, 2019 Marcus Heatherly 498 Views Alzheimer’s Disease, biotechnology stocks, blood diagnostic LymPro Test 2.0, healthcare, Intellectual Property, medical, Medical Stocks, neurodegenerative disorders, neurology, patented, pharmaceutical stocks, regenerative medicine and ophthalmology, testing

REHOVOT, Israel and NEW YORK, April 08, 2019 (GLOBE NEWSWIRE) — Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics

Uncategorized

BriaCell’s Lead Candidate Combined With KEYTRUDA®: Strong Evidence of Rapid Additive or Synergistic Anti-Tumor Activity

April 3, 2019April 3, 2019 Marcus Heatherly 393 Views biotechnology company, Bria-IMT, Bria-OTS, briacell, BriaDX, fibrotic diseases, healthcare, immuno-oncology focused, medical, Phase I/IIa clinical trial

As presented at the American Association for Cancer Research (AACR) annual meeting: early efficacy data for the first six advanced

Radio Interviews

Interview: CEO Allen Davidoff of XORTX Therapeutics Inc.(OTCQB: XRTXF)

April 3, 2019April 2, 2019 Marcus Heatherly 509 Views biopharmaceutical company, cardiovascular disease, Diabetes, diabetic nephropathy and polycystic kidney disease, healthcare, innovative therapies, kidney disease, patent, pharmaceutical stocks

CEO Allen Davidoff of XORTX Therapeutics Inc., talks about their focus of developing therapies for kidney disease, diabetic nephropathy, and cardiovascular disease.

Uncategorized

CytoDyn and Samsung BioLogics Enter into Agreement to Manufacture $1 Billion Worth of Leronlimab (PRO 140) to Meet Expected Demand for Future Revenues Post-Approval

April 2, 2019April 2, 2019 Marcus Heatherly 633 Views Colon Cancer, healthcare, humanized monoclonal antibodies, Leronlimab, less frequent dosing, medical, minimal side effects, Pro 140, protects healthy cells, treatment and prevention of HIV

VANCOUVER, Washington, April 02, 2019 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”) a late stage biotechnology company

Radio Interviews

Featured Interview: CEO Phillipe Deschamps of Helius Medical Technologies, Inc. (NASDAQ: HSDT)

March 20, 2019March 19, 2019 Marcus Heatherly 528 Views Canada, healthcare, Helius Medical Technologies Inc., HSDT, medical, Montreal, PONS, service, targeted therapy, tech, therapy, Treatment, US

Phillipe Deschamps of Helius Medical Technologies, Inc., discusses their PoNS technology, working with Health Canada, and possible timeline for receiving FDA results.